Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head Injuries, Penetrating | 8 | 2023 | 54 | 3.180 |
Why?
|
Brain Injuries | 8 | 2023 | 160 | 2.220 |
Why?
|
Emergency Service, Hospital | 4 | 2021 | 484 | 1.810 |
Why?
|
Inpatients | 4 | 2021 | 295 | 1.760 |
Why?
|
Cerebral Hemorrhage | 11 | 2022 | 325 | 1.660 |
Why?
|
Stroke | 8 | 2024 | 959 | 1.620 |
Why?
|
Brain Injuries, Traumatic | 5 | 2023 | 86 | 1.370 |
Why?
|
Brain Ischemia | 4 | 2020 | 397 | 1.250 |
Why?
|
Thrombolytic Therapy | 4 | 2021 | 220 | 0.950 |
Why?
|
Intracranial Hemorrhages | 3 | 2020 | 119 | 0.900 |
Why?
|
Wounds, Gunshot | 2 | 2020 | 71 | 0.870 |
Why?
|
Intracranial Pressure | 3 | 2023 | 77 | 0.850 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2020 | 4 | 0.790 |
Why?
|
Vascular System Injuries | 1 | 2021 | 29 | 0.790 |
Why?
|
Hypopituitarism | 1 | 2020 | 19 | 0.790 |
Why?
|
Adrenal Insufficiency | 1 | 2020 | 23 | 0.780 |
Why?
|
Intracranial Hypertension | 2 | 2020 | 48 | 0.740 |
Why?
|
Intracranial Thrombosis | 1 | 2020 | 26 | 0.730 |
Why?
|
Neurologic Examination | 1 | 2020 | 118 | 0.720 |
Why?
|
Thrombectomy | 2 | 2024 | 157 | 0.710 |
Why?
|
Hypothyroidism | 1 | 2020 | 232 | 0.680 |
Why?
|
Decision Support Techniques | 1 | 2020 | 160 | 0.660 |
Why?
|
Ischemic Attack, Transient | 1 | 2020 | 181 | 0.660 |
Why?
|
Retrospective Studies | 19 | 2024 | 8431 | 0.620 |
Why?
|
Endovascular Procedures | 1 | 2019 | 218 | 0.540 |
Why?
|
Brain Death | 4 | 2020 | 67 | 0.460 |
Why?
|
Humans | 57 | 2024 | 86281 | 0.450 |
Why?
|
Hematoma | 3 | 2021 | 104 | 0.410 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2022 | 51 | 0.410 |
Why?
|
Injury Severity Score | 2 | 2021 | 111 | 0.380 |
Why?
|
Neurosurgical Procedures | 5 | 2023 | 213 | 0.350 |
Why?
|
Cryotherapy | 1 | 2009 | 29 | 0.340 |
Why?
|
Body Temperature Regulation | 1 | 2009 | 56 | 0.340 |
Why?
|
Middle Aged | 26 | 2024 | 24957 | 0.330 |
Why?
|
Prognosis | 7 | 2021 | 3669 | 0.320 |
Why?
|
Fever | 1 | 2009 | 125 | 0.320 |
Why?
|
Brain Edema | 3 | 2020 | 50 | 0.310 |
Why?
|
Brain Stem | 4 | 2020 | 165 | 0.310 |
Why?
|
Aged | 17 | 2024 | 18353 | 0.290 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2008 | 136 | 0.280 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 151 | 0.280 |
Why?
|
Treatment Outcome | 12 | 2024 | 7949 | 0.280 |
Why?
|
Neurology | 2 | 2017 | 69 | 0.270 |
Why?
|
Time Factors | 5 | 2021 | 5198 | 0.270 |
Why?
|
Male | 26 | 2024 | 40860 | 0.270 |
Why?
|
Female | 30 | 2024 | 44405 | 0.260 |
Why?
|
Intensive Care Units | 3 | 2023 | 373 | 0.250 |
Why?
|
Heart Arrest | 2 | 2022 | 264 | 0.250 |
Why?
|
Critical Care | 3 | 2017 | 368 | 0.240 |
Why?
|
Coma | 2 | 2021 | 44 | 0.240 |
Why?
|
Evidence-Based Medicine | 2 | 2017 | 429 | 0.240 |
Why?
|
Decompressive Craniectomy | 1 | 2023 | 18 | 0.220 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 1671 | 0.220 |
Why?
|
Intracranial Aneurysm | 3 | 2020 | 158 | 0.220 |
Why?
|
Seizures | 2 | 2020 | 293 | 0.220 |
Why?
|
Models, Biological | 1 | 2009 | 1748 | 0.200 |
Why?
|
Neurosurgery | 2 | 2021 | 84 | 0.200 |
Why?
|
Length of Stay | 2 | 2023 | 697 | 0.200 |
Why?
|
Embolization, Therapeutic | 1 | 2024 | 238 | 0.200 |
Why?
|
Head Injuries, Closed | 1 | 2020 | 11 | 0.200 |
Why?
|
Hospitalization | 3 | 2021 | 844 | 0.200 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2021 | 12 | 0.200 |
Why?
|
Hypocalcemia | 1 | 2020 | 41 | 0.190 |
Why?
|
Pituitary-Adrenal System | 1 | 2020 | 64 | 0.190 |
Why?
|
Prospective Studies | 4 | 2022 | 4194 | 0.190 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2020 | 17 | 0.190 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2021 | 67 | 0.190 |
Why?
|
Heart Conduction System | 1 | 2021 | 108 | 0.190 |
Why?
|
Apnea | 1 | 2020 | 29 | 0.190 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2020 | 81 | 0.190 |
Why?
|
Hemostatics | 1 | 2021 | 56 | 0.190 |
Why?
|
Triage | 1 | 2021 | 108 | 0.190 |
Why?
|
Heuristics | 1 | 2020 | 15 | 0.190 |
Why?
|
Prevalence | 3 | 2021 | 1239 | 0.190 |
Why?
|
Amantadine | 1 | 2020 | 18 | 0.190 |
Why?
|
Nootropic Agents | 1 | 2020 | 10 | 0.190 |
Why?
|
Blood Coagulation Disorders | 1 | 2021 | 63 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 7 | 2021 | 2594 | 0.180 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 132 | 0.180 |
Why?
|
Mortality | 1 | 2020 | 148 | 0.180 |
Why?
|
Arrhythmias, Cardiac | 1 | 2021 | 187 | 0.180 |
Why?
|
Cognition Disorders | 2 | 2020 | 236 | 0.180 |
Why?
|
Heart Rate | 3 | 2021 | 492 | 0.180 |
Why?
|
Practice Guidelines as Topic | 3 | 2017 | 1030 | 0.180 |
Why?
|
Guillain-Barre Syndrome | 1 | 2019 | 16 | 0.180 |
Why?
|
Caregivers | 1 | 2021 | 151 | 0.180 |
Why?
|
Respiratory Therapy | 1 | 2019 | 14 | 0.170 |
Why?
|
Thyroid Gland | 1 | 2020 | 270 | 0.170 |
Why?
|
Family | 1 | 2021 | 311 | 0.170 |
Why?
|
Tissue Plasminogen Activator | 1 | 2020 | 162 | 0.170 |
Why?
|
Incidence | 3 | 2020 | 1568 | 0.170 |
Why?
|
Survivors | 1 | 2020 | 225 | 0.170 |
Why?
|
Practice Patterns, Physicians' | 2 | 2019 | 578 | 0.170 |
Why?
|
Acute Disease | 1 | 2020 | 824 | 0.170 |
Why?
|
Drug Therapy | 1 | 2019 | 70 | 0.170 |
Why?
|
Electrocardiography | 1 | 2021 | 478 | 0.170 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 200 | 0.170 |
Why?
|
Hospitals, University | 1 | 2019 | 193 | 0.160 |
Why?
|
Thrombocytosis | 1 | 2018 | 8 | 0.160 |
Why?
|
Plateletpheresis | 1 | 2018 | 2 | 0.160 |
Why?
|
Carotid Artery Thrombosis | 1 | 2018 | 5 | 0.160 |
Why?
|
Health Status Disparities | 1 | 2020 | 170 | 0.160 |
Why?
|
Patient Readmission | 1 | 2022 | 324 | 0.160 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 310 | 0.160 |
Why?
|
Influenza Vaccines | 1 | 2019 | 142 | 0.160 |
Why?
|
Chicago | 2 | 2020 | 1377 | 0.160 |
Why?
|
Feasibility Studies | 1 | 2020 | 751 | 0.160 |
Why?
|
Clinical Decision-Making | 1 | 2020 | 255 | 0.160 |
Why?
|
Action Potentials | 1 | 2021 | 573 | 0.150 |
Why?
|
Adult | 18 | 2024 | 25577 | 0.140 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 1610 | 0.140 |
Why?
|
Disease Management | 1 | 2018 | 327 | 0.140 |
Why?
|
Societies, Medical | 2 | 2017 | 572 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Macroglossia | 1 | 2014 | 2 | 0.120 |
Why?
|
Brain | 4 | 2013 | 2211 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2017 | 242 | 0.120 |
Why?
|
Reproducibility of Results | 1 | 2020 | 2699 | 0.120 |
Why?
|
Glasgow Coma Scale | 2 | 2023 | 65 | 0.120 |
Why?
|
Pregnatrienes | 3 | 2007 | 14 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2013 | 47 | 0.110 |
Why?
|
Risk Assessment | 4 | 2021 | 2253 | 0.110 |
Why?
|
Subarachnoid Hemorrhage, Traumatic | 1 | 2012 | 3 | 0.110 |
Why?
|
Ammonia | 1 | 2011 | 37 | 0.100 |
Why?
|
Hyperammonemia | 1 | 2011 | 10 | 0.100 |
Why?
|
Neuromuscular Diseases | 1 | 2012 | 30 | 0.100 |
Why?
|
Hepatic Encephalopathy | 1 | 2011 | 39 | 0.100 |
Why?
|
Risk Factors | 6 | 2022 | 5397 | 0.100 |
Why?
|
Hypothermia, Induced | 1 | 2011 | 74 | 0.100 |
Why?
|
Hospitals | 1 | 2013 | 290 | 0.100 |
Why?
|
Tissue Donors | 1 | 2013 | 462 | 0.090 |
Why?
|
Respiratory Insufficiency | 1 | 2012 | 149 | 0.090 |
Why?
|
Qualitative Research | 2 | 2021 | 256 | 0.090 |
Why?
|
Glioblastoma | 1 | 2012 | 254 | 0.090 |
Why?
|
Machine Learning | 2 | 2022 | 232 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 309 | 0.090 |
Why?
|
Blood Physiological Phenomena | 1 | 2009 | 9 | 0.090 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2011 | 189 | 0.090 |
Why?
|
Ice | 1 | 2009 | 11 | 0.090 |
Why?
|
Quadriplegia | 1 | 2008 | 22 | 0.090 |
Why?
|
Hernia | 1 | 2008 | 23 | 0.080 |
Why?
|
Sodium Chloride | 1 | 2009 | 86 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 850 | 0.080 |
Why?
|
Cold Temperature | 1 | 2009 | 157 | 0.080 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2007 | 1 | 0.080 |
Why?
|
Eye Movements | 1 | 2008 | 119 | 0.080 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 429 | 0.080 |
Why?
|
Encephalitis | 1 | 2008 | 104 | 0.080 |
Why?
|
Aneurysm, Ruptured | 1 | 2007 | 51 | 0.080 |
Why?
|
Tremor | 1 | 2007 | 22 | 0.080 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2012 | 929 | 0.070 |
Why?
|
Fingers | 1 | 2007 | 68 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2021 | 6481 | 0.070 |
Why?
|
Brain Neoplasms | 1 | 2012 | 763 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2007 | 126 | 0.070 |
Why?
|
Pandemics | 2 | 2023 | 739 | 0.070 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2005 | 3 | 0.070 |
Why?
|
Anti-Dyskinesia Agents | 1 | 2005 | 4 | 0.070 |
Why?
|
Torticollis | 1 | 2005 | 11 | 0.070 |
Why?
|
Dystonic Disorders | 1 | 2005 | 7 | 0.070 |
Why?
|
Botulinum Toxins | 1 | 2005 | 16 | 0.070 |
Why?
|
Patient Admission | 2 | 2021 | 112 | 0.060 |
Why?
|
Craniotomy | 1 | 2005 | 88 | 0.060 |
Why?
|
Decompression, Surgical | 1 | 2005 | 87 | 0.060 |
Why?
|
Vasospasm, Intracranial | 1 | 2004 | 36 | 0.060 |
Why?
|
Minority Groups | 1 | 2005 | 132 | 0.060 |
Why?
|
Cohort Studies | 3 | 2021 | 2759 | 0.060 |
Why?
|
Radial Artery | 1 | 2024 | 33 | 0.060 |
Why?
|
Adolescent | 5 | 2023 | 8968 | 0.060 |
Why?
|
Catheters | 1 | 2024 | 68 | 0.060 |
Why?
|
Latin America | 1 | 2023 | 14 | 0.060 |
Why?
|
Income | 1 | 2023 | 75 | 0.060 |
Why?
|
Disease Progression | 2 | 2021 | 1531 | 0.060 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 53 | 0.050 |
Why?
|
Death | 1 | 2023 | 72 | 0.050 |
Why?
|
Resuscitation | 1 | 2022 | 100 | 0.050 |
Why?
|
Cranial Fossa, Posterior | 2 | 2014 | 25 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2023 | 268 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 1562 | 0.050 |
Why?
|
Electrolytes | 1 | 2020 | 52 | 0.050 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 169 | 0.050 |
Why?
|
Life Support Care | 1 | 2021 | 48 | 0.050 |
Why?
|
Young Adult | 2 | 2023 | 5961 | 0.050 |
Why?
|
Spinal Injuries | 1 | 2020 | 22 | 0.050 |
Why?
|
Double-Blind Method | 4 | 2007 | 1822 | 0.050 |
Why?
|
Withholding Treatment | 1 | 2021 | 111 | 0.050 |
Why?
|
Hematologic Diseases | 1 | 2020 | 79 | 0.040 |
Why?
|
Craniocerebral Trauma | 1 | 2020 | 52 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2013 | 293 | 0.040 |
Why?
|
Patient Participation | 1 | 2021 | 216 | 0.040 |
Why?
|
Sodium | 1 | 2020 | 340 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2020 | 69 | 0.040 |
Why?
|
Snoring | 2 | 1996 | 12 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2020 | 119 | 0.040 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2020 | 234 | 0.040 |
Why?
|
Health Personnel | 1 | 2021 | 202 | 0.040 |
Why?
|
Recovery of Function | 1 | 2020 | 272 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2021 | 347 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2021 | 294 | 0.040 |
Why?
|
Anticoagulants | 1 | 2021 | 404 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 464 | 0.040 |
Why?
|
Glasgow Outcome Scale | 2 | 2007 | 7 | 0.040 |
Why?
|
Databases, Factual | 1 | 2021 | 808 | 0.040 |
Why?
|
Sex Factors | 1 | 2020 | 1053 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2014 | 152 | 0.040 |
Why?
|
Recurrence | 1 | 2019 | 1137 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 610 | 0.040 |
Why?
|
Biomedical Research | 1 | 2020 | 375 | 0.030 |
Why?
|
Decision Making | 1 | 2021 | 641 | 0.030 |
Why?
|
Neuroprotective Agents | 2 | 2007 | 94 | 0.030 |
Why?
|
Catalepsy | 1 | 1994 | 3 | 0.030 |
Why?
|
Sleep Wake Disorders | 1 | 1996 | 115 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 1994 | 48 | 0.030 |
Why?
|
Biomarkers | 1 | 2021 | 1709 | 0.030 |
Why?
|
Primary Dysautonomias | 1 | 2014 | 6 | 0.030 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2014 | 17 | 0.030 |
Why?
|
Amines | 1 | 2014 | 27 | 0.030 |
Why?
|
Tracheostomy | 1 | 2014 | 42 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2014 | 83 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 2014 | 203 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2012 | 18 | 0.030 |
Why?
|
Dexamethasone | 1 | 2014 | 326 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2008 | 3347 | 0.030 |
Why?
|
Central Nervous System Stimulants | 1 | 1994 | 216 | 0.030 |
Why?
|
Abdomen | 1 | 1992 | 121 | 0.030 |
Why?
|
Dacarbazine | 1 | 2012 | 102 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2011 | 134 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2011 | 83 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2012 | 138 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 1991 | 48 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 339 | 0.020 |
Why?
|
Bevacizumab | 1 | 2012 | 281 | 0.020 |
Why?
|
Child | 1 | 2022 | 6913 | 0.020 |
Why?
|
Radiography | 1 | 2013 | 812 | 0.020 |
Why?
|
United States | 1 | 2023 | 6637 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 1991 | 124 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 509 | 0.020 |
Why?
|
Pons | 1 | 2008 | 24 | 0.020 |
Why?
|
Methylprednisolone Hemisuccinate | 1 | 2008 | 10 | 0.020 |
Why?
|
Sleep | 1 | 1992 | 440 | 0.020 |
Why?
|
Hydrocephalus | 1 | 2008 | 101 | 0.020 |
Why?
|
Prednisone | 1 | 2008 | 255 | 0.020 |
Why?
|
Toes | 1 | 2007 | 14 | 0.020 |
Why?
|
Syndrome | 1 | 2008 | 446 | 0.020 |
Why?
|
Oxygen | 1 | 1992 | 725 | 0.020 |
Why?
|
Hypertension | 1 | 1996 | 1139 | 0.020 |
Why?
|
Hypoxia | 1 | 1992 | 638 | 0.020 |
Why?
|
Functional Laterality | 1 | 2007 | 201 | 0.020 |
Why?
|
Mandibular Diseases | 1 | 2005 | 16 | 0.020 |
Why?
|
Mouth Diseases | 1 | 2005 | 15 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 3087 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2011 | 2227 | 0.020 |
Why?
|
Wakefulness | 2 | 1996 | 134 | 0.020 |
Why?
|
Posture | 1 | 2005 | 125 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2004 | 196 | 0.020 |
Why?
|
Postoperative Complications | 1 | 1992 | 2183 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2007 | 3616 | 0.010 |
Why?
|
Child, Preschool | 1 | 2005 | 3608 | 0.010 |
Why?
|
Mice | 1 | 2011 | 11313 | 0.010 |
Why?
|
Sex Ratio | 1 | 1996 | 22 | 0.010 |
Why?
|
Social Adjustment | 1 | 1996 | 46 | 0.010 |
Why?
|
Sleep Stages | 1 | 1996 | 45 | 0.010 |
Why?
|
Polysomnography | 1 | 1996 | 150 | 0.010 |
Why?
|
Arousal | 1 | 1996 | 170 | 0.010 |
Why?
|
Fatigue | 1 | 1996 | 174 | 0.010 |
Why?
|
Placebos | 1 | 1994 | 218 | 0.010 |
Why?
|
Respiration | 1 | 1996 | 261 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1994 | 399 | 0.010 |
Why?
|
Body Mass Index | 1 | 1996 | 770 | 0.010 |
Why?
|
Animals | 1 | 2011 | 26518 | 0.010 |
Why?
|
Oximetry | 1 | 1992 | 84 | 0.010 |
Why?
|
France | 1 | 1991 | 47 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 1996 | 521 | 0.010 |
Why?
|
Age Factors | 1 | 1996 | 1842 | 0.010 |
Why?
|
Drug Utilization | 1 | 1991 | 65 | 0.010 |
Why?
|
Anxiety | 1 | 1991 | 287 | 0.010 |
Why?
|
Blood Pressure | 1 | 1994 | 1143 | 0.010 |
Why?
|
Depression | 1 | 1991 | 472 | 0.000 |
Why?
|